Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Sequent Scientific Limited, is an unlisted public company incorporated on 28 June, 1985. It is classified as a public limited company and is located in Thane West, Maharashtra. It's authorized share capital is INR 80.00 cr and the total paid-up capital is INR 49.92 cr.
Sequent Scientific Limited's operating revenue range is INR 100 cr - 500 cr for the financial year ending on 31 March, 2023. It's book networth has increased by 1.66%.
Read more
This action will use 1 of your credits. Are you sure you want to go ahead?
** All rupee values in INR crores. Based on March 2024 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
State | Type | Address |
---|
Designation | Name | DIN/PAN | Tenure |
---|---|---|---|
Director | Milind Shripad Sarwate | 00109854 | 5 years |
Director | Kamal Kishore Sharma | 00209430 | 5 years |
Director | Hari Babu Bodepudi | 01119687 | 2 years |
Director | Neeraj Bharadwaj | 01314963 | 5 years |
Director | Rajaram Narayanan | 02977405 | 3 years |
Kmp | Phillip Trott | <HIDDEN> | 1 years |
Director | Kausalya Santhanam | 06999168 | 11 years |
Director | Gregory John Andrews | 08904518 | 5 years |
Director | Fabian Martin Kausche | 08976500 | 4 years |
Director | Vedprakash Shantalingappa Ragate | 10578409 | 1 years |
Kmp | Saurav Bhala | <HIDDEN> | 2 years |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Networth | |||||
Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Financials upto March 2024 available in Tofler Pro
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Catalyst Trusteeship Limited
No. of Loans: 1
Total Amount : 360.0 cr
ICICI Bank Limited
No. of Loans: 1
Total Amount : 38.0 cr
Aditya Birla Finance Limited
No. of Loans: 2
Total Amount : 25.0 cr
Name | State / Country | Incorporation Year | Paidup Capital |
---|---|---|---|
ALIVIRA ANIMAL HEALTH LIMITED | Maharashtra | 2013 | ₹ 47.8 Cr |
Read more
The incorporation date of SEQUENT SCIENTIFIC LIMITED is 28 June, 1985
The authorized share capital of SEQUENT SCIENTIFIC LIMITED is INR ₹ 80.0 Cr.
The paid-up capital of SEQUENT SCIENTIFIC LIMITED is INR ₹ 49.9 Cr.
The registered address of SEQUENT SCIENTIFIC LIMITED is 301, 3rd Floor, Dosti Pinnacle, Plot No.E7 Road No.22, Wag le Industrial Estate, NA Thane west Maharashtra - 400604
The CIN number of SEQUENT SCIENTIFIC LIMITED is L99999MH1985PLC036685.